Journal
BIOCHEMICAL JOURNAL
Volume 443, Issue -, Pages 485-490Publisher
PORTLAND PRESS LTD
DOI: 10.1042/BJ20111057
Keywords
bipolar disorder; lithium; 3 '-5 ' phosphoadenosine phosphate (pAp); poly(ADP-ribose) polymerase 1 (PARP-1)
Categories
Funding
- Centre National de la Recherche Scientifique
- Institut Pasteur
- Universite Pierre et Marie Curie
- Association pour la Recherche sur la Cancer [5950, 7659]
Ask authors/readers for more resources
pAp (3'-5' phosphoadenosine phosphate) is a by-product of sulfur and lipid metabolism and has been shown to have strong inhibitory properties on RNA catabolism. In the present paper we report a new target of pAp, PARP-1 [poly(ADP-ribose) polymerase 1], a key enzyme in the detection of DNA single-strand breaks. We show that pAp can interact with PARP-1 and inhibit its poly(ADP-ribosyl)ation activity. In vitro, inhibition of PARP-1 was detectable at micromolar concentrations of pAp and altered both PARP-1 automodification and heteromodification of histones. Analysis of the kinetic parameters revealed that pAp acted as a mixed inhibitor that modulated both the K-m and the V-max of PARP-1. In addition, we showed that upon treatment with lithium, a very potent inhibitor of the enzyme responsible for pAp recycling, HeLa cells exhibited a reduced level of poly(ADP-ribosyl)ation in response to oxidative stress. From these results, we propose that pAp might be a physiological regulator of PARP-1 activity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available